Chandi C Mandal
Chandi C Mandal is an expert in Biochemistry at Central University of Rajasthan (India). As of October 2026, ScienceLeadR ranks Chandi C Mandal in the top 1% of experts in India for Breast Neoplasms and Breast Diseases. Chandi C Mandal has authored 90 publications, the most recent in 2026. SLR score: 299 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Endocrinology - Oncology - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 90
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Editorial: Bone metastases in endocrine cancers: advances in diagnosis, treatment, and prevention. PMID 42729259 — neoplasms, neoplasm metastasis, diagnosis, therapeutics, endocrine system diseases | Front Endocrinol (Lausanne) | 2026 | 0 |
| Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches. PMID 42482438 — malaria, pharmaceutical preparations, dna gyrase, parasites, antimalarials, dna, drug resistance | Chem Biol Drug Des | 2026 | 0 |
| ZNF468 Exhibits Oncogenic Activity by Regulating Unexplored ZNF707 in Breast Cancer. PMID 42219449 — cells, genes, cell proliferation, breast neoplasms, transcription factors, neoplasms, breast, therapeutics, tissues | J Gene Med | 2026 | 0 |
| Identification of novel pyrazolo[4,3-c]pyridine and diazepane derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B. PMID 41661129 — protein tyrosine phosphatases, drug discovery, mycobacterium, pharmaceutical preparations, phosphoric monoester hydrolases, tuberculosis, immunity, tyrosine, therapeutics, molecular dynamics simulation, mycobacterium tuberculosis, infections | Infect Immun | 2026 | 0 |
| Targeting Plasmodium falciparum Single-Stranded DNA-Binding Protein: Discovery of New Scaffold Compounds Effective against Drug-Sensitive and Artemisinin-Resistant Strains. PMID 40946223 — malaria, pharmaceutical preparations, dna-binding proteins, dna, single-stranded, antimalarials, dna, drug resistance | ChemMedChem | 2025 | 0 |
LeadR Networks
Main global connection map